ISB News

‘A Better Blood Test for Liver Damage’

Chemical & Engineering News highlighted ISB’s recent publication (Identifying Organ-Specific Blood Biomarkers for Acute Liver Injury) in the Journal of Proteome Research.

“For many years, clinicians have relied on assays for two enzymes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST), to detect liver injury. These biomarkers have limitations, says Leroy Hood of the Institute for Systems Biology, such as a short half-life and a tendency to underreport damage in certain individuals. Hood has been thinking about how to find better disease biomarkers for many years. ‘I had this idea that if we could identify organ-enriched proteins that actually appear in the blood, they would be fantastic biomarkers of disease in an organ.’ ” – C & En

Read the C&En article

Recent Articles

  • Valerie Logan Luncheon emcee Heather Logan

    ‘Innovation to Impact:’ 8th Annual Valerie Logan Luncheon Shines Light on ISB Education

    The 8th Annual Valerie Logan Luncheon celebrated ISB Education’s mission of engaging entire school systems — from principals and administrators to teachers and students — to ensure all students are STEM literate. Nearly 100 people attended the event at ISB, and generously gave more than $100,000 for ISB Education.

  • Malaria Researchers’ Findings May Have Implications for Preventing Spread of Deadly Disease

    ISB researchers and their collaborators are using systems biology approaches to learn how the malaria parasite is able to transfer to humans via the bite of an infected mosquito. The information they have uncovered may help identify new ways to prevent people from contracting the deadly disease.

  • ISB Unveils New Brand Ahead of 20th Anniversary

    We created a new brand identity — including logo and tag line — to reflect ISB’s evolution since our inception in 2000, and ahead of our 20th anniversary. ISB is proud to be a part of the vibrant research community in Seattle, and is committed to translational and collaborative science.